DATA ANALYSIS PROCEDURES, PROGRAMME AND DATA DOCUMENTATION
Data Usage and Management
All processed FDA data will be maintained by the FDM system subject to periodic deletion as determined by the CPFS and in accordance with The Company record retention policies.
The FSEA will be responsible for developing reports summarizing the information obtained through the FDA Program. The reports will include summaries of the most recent information obtained through the FDA Program as well as trend information to demonstrate the effectiveness of prior corrective actions.
These reports will be distributed to Flight Operations, Flight Training, Flight Safety, Maintenance Engineering, and other involved stakeholders on a regular basis. The FSEA will solicit recommendations from the recipients of the reports in order to improve their usefulness as the program proceeds.
Flight Data Collection and Analysis
The manner in which FDA data is processed is illustrated in Figure 2 below. The Flight Data Analyst retrieves data from the aircraft and downloads it to the FDA desktop and will process the recorded flight data. The flight data will be processed to determine what occurred and whether the recorded information was legitimate. A preliminary analysis will use the FDM system to interpret identified events or trends and determine whether the information was valid or invalid because of bad data, a faulty sensor, or some other invalidating factor. In the event that the data reveal a situation of immediate concern to Maintenance Engineering, the CPFS will notify that department.
Program trend reports of the aggregate data are developed by the Flight Data Analyst on a regular basis for presentation to stakeholders for use in developing corrective actions or for monitoring of operational issues.
Data Classifications and Definitions
Parameters and measurements used in the FDA program are programmed into the FDM system to measure events and/or monitor trends. The performance limits that define these definitions will be continually reviewed by the FDA Monitoring Team to determine they are consistent with the FDA program goals, applicable publications, and guidance materials, which may include, but are not limited to, the following:
Data Definition Maintenance
The procedures for validating, reviewing, and defining event and trend definitions will be established by the CPFS and the FMT and they will determine whether the information is valid and reflects The Company qualification and performance standards, training practices, and aircraft performance limits. All changes in the event and trend definitions will be logged and the CPFS will maintain the records.
Data Review and Evaluation
All data recorded by the FDA Program will be evaluated by the FMT on a periodic basis as determined by the CPFS. FDA data should be evaluated to determine if the program is accurately monitoring collected information for events and trends.
The review and evaluation of the measurements, profiles, events, and trends used in the FDA Program should reflect changes, updates, or enhancements to policy and procedures within all stakeholders’ departments.
Consideration should also be given to any changes, updates, or enhancements to policies and procedures within the DCAM and industry.
Data Trending and Record Retention
De-identified flight data stored in the FDM system will be periodically deleted as determined by the CPFS. Raw data shall not be used beyond 6 months after analysis on the ground. All event data shall be destroyed after 12 months of completion of the flight except for events that require further analysis as determined by the CPFS. Such event data may be kept until completion of the investigation. Raw data or event data used to substantiate information from accident/incident reports, reports submitted by the aviation authorities and other sources may be kept until no longer required for investigation purposes.
Re-identification of data that has not been used to substantiate information from accident/incident reports, reports submitted by aviation authorities and other sources shall be only made with consent of the FMT and shall solely be used for remedial training or advice to the flight crew concerned.
Corrective action when adverse safety trends are discovered
Data analyzed by the FMT shall be subjected to recommendations being made to prevent recurrence of adverse safety trends. These recommendations may include changes to The Company or manufacturer procedures, ATC or the regulators.
Pilots may also be called for detailed information of a particular finding. The FDA Monitoring Team will interview the pilot and submit its findings to the CPFS for follow up action.
Some instances may require the intervention of the Flight Safety Section. In the event an adverse trend affecting safety is picked up by the FDA program and awaiting the FMT to convene would take considerable time, then the CPFS has the jurisdiction to interview the pilot concerned.
Operational Development
CPFS will develop appropriate documentation for support of the FDA operation. This documentation will be used to provide routine support for the process and facilitate any personnel transitions that may occur during the program.
Information and Data Control
CPFS will maintain a history of the information used in the FDA program. When a FDA or safety issue is identified, a log will be maintained to provide a reference document. This document will provide a way to track how The Company addresses trends revealed by analysis of the FDA data. This will include:
Accident and Incident Investigation
The Company for accident and incident investigation may use data obtained from the FDA program to substantiate or follow up on information from accident/incident reports and reports submitted by Aviation Authorities. FDA data may be used to assist findings of an accident or incident investigation report.
Feedback of FDA Results to Crew
A newsletter, entitled Flight Safety Newsletter, is produced by the Safety Department at least bi-annually to coincide with the event review cycle. It provides de-identified information about event trends and which airports/runways are over-represented in the statistics. This newsletter is circulated to all pilots.
All processed FDA data will be maintained by the FDM system subject to periodic deletion as determined by the CPFS and in accordance with The Company record retention policies.
The FSEA will be responsible for developing reports summarizing the information obtained through the FDA Program. The reports will include summaries of the most recent information obtained through the FDA Program as well as trend information to demonstrate the effectiveness of prior corrective actions.
These reports will be distributed to Flight Operations, Flight Training, Flight Safety, Maintenance Engineering, and other involved stakeholders on a regular basis. The FSEA will solicit recommendations from the recipients of the reports in order to improve their usefulness as the program proceeds.
Flight Data Collection and Analysis
The manner in which FDA data is processed is illustrated in Figure 2 below. The Flight Data Analyst retrieves data from the aircraft and downloads it to the FDA desktop and will process the recorded flight data. The flight data will be processed to determine what occurred and whether the recorded information was legitimate. A preliminary analysis will use the FDM system to interpret identified events or trends and determine whether the information was valid or invalid because of bad data, a faulty sensor, or some other invalidating factor. In the event that the data reveal a situation of immediate concern to Maintenance Engineering, the CPFS will notify that department.
Program trend reports of the aggregate data are developed by the Flight Data Analyst on a regular basis for presentation to stakeholders for use in developing corrective actions or for monitoring of operational issues.
Data Classifications and Definitions
Parameters and measurements used in the FDA program are programmed into the FDM system to measure events and/or monitor trends. The performance limits that define these definitions will be continually reviewed by the FDA Monitoring Team to determine they are consistent with the FDA program goals, applicable publications, and guidance materials, which may include, but are not limited to, the following:
- Flight Crew Operations Manual (FCOM);
- Quick Reference Handbook (QRH);
- Flight Crew Training Manuals;
- Airplane Flight Manual (AFM); and
- Manufacturer Maintenance Manuals
Data Definition Maintenance
The procedures for validating, reviewing, and defining event and trend definitions will be established by the CPFS and the FMT and they will determine whether the information is valid and reflects The Company qualification and performance standards, training practices, and aircraft performance limits. All changes in the event and trend definitions will be logged and the CPFS will maintain the records.
Data Review and Evaluation
All data recorded by the FDA Program will be evaluated by the FMT on a periodic basis as determined by the CPFS. FDA data should be evaluated to determine if the program is accurately monitoring collected information for events and trends.
The review and evaluation of the measurements, profiles, events, and trends used in the FDA Program should reflect changes, updates, or enhancements to policy and procedures within all stakeholders’ departments.
Consideration should also be given to any changes, updates, or enhancements to policies and procedures within the DCAM and industry.
Data Trending and Record Retention
De-identified flight data stored in the FDM system will be periodically deleted as determined by the CPFS. Raw data shall not be used beyond 6 months after analysis on the ground. All event data shall be destroyed after 12 months of completion of the flight except for events that require further analysis as determined by the CPFS. Such event data may be kept until completion of the investigation. Raw data or event data used to substantiate information from accident/incident reports, reports submitted by the aviation authorities and other sources may be kept until no longer required for investigation purposes.
Re-identification of data that has not been used to substantiate information from accident/incident reports, reports submitted by aviation authorities and other sources shall be only made with consent of the FMT and shall solely be used for remedial training or advice to the flight crew concerned.
Corrective action when adverse safety trends are discovered
Data analyzed by the FMT shall be subjected to recommendations being made to prevent recurrence of adverse safety trends. These recommendations may include changes to The Company or manufacturer procedures, ATC or the regulators.
Pilots may also be called for detailed information of a particular finding. The FDA Monitoring Team will interview the pilot and submit its findings to the CPFS for follow up action.
Some instances may require the intervention of the Flight Safety Section. In the event an adverse trend affecting safety is picked up by the FDA program and awaiting the FMT to convene would take considerable time, then the CPFS has the jurisdiction to interview the pilot concerned.
Operational Development
CPFS will develop appropriate documentation for support of the FDA operation. This documentation will be used to provide routine support for the process and facilitate any personnel transitions that may occur during the program.
Information and Data Control
CPFS will maintain a history of the information used in the FDA program. When a FDA or safety issue is identified, a log will be maintained to provide a reference document. This document will provide a way to track how The Company addresses trends revealed by analysis of the FDA data. This will include:
- A description of the identified issue;
- Analysis that was accomplished;
- Specific corrective actions or recommendations taken or made;
- Personnel who were notified (e.g., flight crew members [de-identified],
- Engineering Maintenance, Flight Operations, Flight Training, Flight Safety);and
- Resolution of actions or recommendations.
Accident and Incident Investigation
The Company for accident and incident investigation may use data obtained from the FDA program to substantiate or follow up on information from accident/incident reports and reports submitted by Aviation Authorities. FDA data may be used to assist findings of an accident or incident investigation report.
Feedback of FDA Results to Crew
A newsletter, entitled Flight Safety Newsletter, is produced by the Safety Department at least bi-annually to coincide with the event review cycle. It provides de-identified information about event trends and which airports/runways are over-represented in the statistics. This newsletter is circulated to all pilots.
DATA ANALYSIS PROCEDURES, PROGRAMME AND DATA DOCUMENTATION
Reviewed by Aviation Lesson
on
2:00 PM
Rating:
Reviewed by Aviation Lesson
on
2:00 PM
Rating:
No comments: